-
Biosimilars
GPhA applauds Congress for establishing an abbreviated... -
Drug Shortages
As members of the public who also are affected by... -
Quality
Science and quality are the cornerstones of the generic... -
Patent Settlements
GPhA vigorously opposes restricting the right of parties in... -
User Fees
GPhA and its member companies support full implementation...
Improving Lives for Less
The Generic Pharmaceutical Association commissioned the IMS Institute for Healthcare Informatics, the leading provider of healthcare market data, to conduct a study of pharmaceutical sales over the past decade. The results of the IMS analysis are astounding. For the 10-year period 2002-2011, the use of generic prescription drugs in place of their brand-name counterparts saved American consumers and the nation’s health care system $1.02 trillion dollars. learn more >
Vision
2012 Annual Report
Vision. In 2012, GPhA transformed its vision into action to improve health care outcomes for millions of patients across the U.S., and made unprecedented progress on the goal to expand access to high quality, more affordble medicines.
The vision theme of the 2012 annual report communicates GPhA's conviction that the first step toward building a successful future is developing the ability to envision it. learn more >
Recent News
Featured Items
